Advances in Urology

Review Article

Laparoscopic Nephroureterectomy and Management of the Distal Ureter: A Review of Current Techniques and Outcomes

Table 2

Oncologic outcomes of LPN versus ONU cases. CR, conventional retroperitoneal; CT, conventional transperitoneal; HAR, hand-assisted retroperitoneal; HAT, hand-assisted transperitoneal; LND, lymph node dissection; LS, laparoscopic stapling; NL, not listed; ONU, open nephroureterectomy; SD, surgeon discretion; TURUO, transurethral resection; TV, transvesical.


Author	Surgery	N	Follow up (mo)	History of bladder tumor specified	Bladder cuff surgery	Path stage (Ta,Tis,T1/T2, T3,T4)	Path grade (1/2/3)	LND	Urothelial recurrence (%)	Local recurrence (%)	Port-site recurrence (%)	Distal recurrence (%)	Disease-specific survival (@ year)

Muntener et al. [8]	CT	39	74	Yes	Open (19), LS (13), other (5)	22/15/2NL	8LG/31HG	No	16 (41)	2 (5)	0 (0)	7 (18)	68 (5)

Schatteman et al. [9]	CT/CR	95/5	20	No	Open (55), Other (45)	54/46	24/28/48	20% of cases	NL	13 (13)	3 (3)	16 (16)	88 (2)

Rouprêt et al. [10]	CT	20	69	No	Open	15/511/15	12LG/8HG	SD	2 (10)	0 (0)	0 (0)	2 (10)	90 (5)
Rouprêt et al. [10]	ONU	26	78	No	Open	15/511/15	7LG/19HG	SD	4 (15)	0 (0)	0 (0)	9 (35)	62 (5)

Okegawa et al. [11]	CR	25	24	Yes	Open	14/119/14	2/17/6	No	5 (20)	0 (0)	0 (0)	2 (8)	91 (2)
Okegawa et al. [11]	ONU	23	29	Yes	Open	14/119/14	1/15/7	No	4 (17)	0 (0)	0 (0)	3 (13)	89 (2)

Tsujihata et al. [12]	CR	25	22	No	Open	12/1315/6	5/15/5	No	7 (28)	0 (0)	0 (0)	0 (0)	64 (2)
Tsujihata et al. [12]	ONU	24	22	No	Open	12/1315/6	0/11/12	No	8 (33)	0 (0)	0 (0)	2 (8)	58 (2)

Manabe et al. [20]	CR	58	14	Excluded	Open	28/3070/96	4/31/23	No	19 (33)	1 (2)	1 (2)	10 (17)	85 (2)
Manabe et al. [20]	ONU	166	28	Excluded	Open	28/3070/96	15/87/64	No	63 (38)	2 (1)	1 (2)	33 (20)	87 (2)

Taweemonkongsap et al. [13]	CR	31	26	Yes	Open	16/15	18LG/13HG	SD	9 (29)	2 (6)	0 (0)	3 (10)	86 (2)
Taweemonkongsap et al. [13]	ONU	29	28	Yes	Open	13/16	10LG/19HG	SD	13 (45)	1 (3)	0 (0)	2 (7)	93 (2)

Chung et al. [14]	HAT	39	48	No	Open	18/21	1/22/16	SD	17 (44)	1 (3)	0 (0)	6 (15)	90 (5)
Chung et al. [14]	ONU	36	60	No	Open	17/19	1/20/15	SD	13 (36)	3 (8)	0 (0)	4 (11)	86 (5)

Raman et al. [15]	HAT	38	32	Yes	Open (30),	27/9	23LG/15HG	No	11 (29)	1 (3)	0 (0)	2 (6)	81 (5)
Raman et al. [15]	ONU	52	51	Yes	TURUO (8)	41/11	33LG/19HG	No	18 (35)	0 (0)	0 (0)	6 (11)	77 (5)

Wolf et al. [16]	HAT	53	25	Yes	TURUO (23), TV (22), Open (6), LS (2)	38/15	18/9/26	SD	(55)	(8)	0 (0)	(16)	80 (3)

Cannon et al. [17]	HAT	34	14	No	Open	17/18	NL	No	8 (24)	0 (0)	0 (0)	2 (6)	NL

Hsueh et al. [21]	HAR	66	38	No	Open	35/31	1/25/38	No	13 (20)	2 (3)	0 (0)	6 (9)	80 (5)
Hsueh et al. [21]	ONU	77	54	No	Open	43/33	3/39/34	No	19 (25)	2 (3)	0 (0)	12 (16)	75 (5)

Chung et al. [18]	HAR	25	32	No	Open	13/12	1/13/11	No	9 (36)	3 (12)	0 (0)	2 (8)	92 (3)
Chung et al. [18]	ONU	41	62	No	Open	18/23	1/23/17	No	13 (32)	3 (7)	0 (0)	5 (12)	92 (3)

Nakashima et al. [19]	HAR	35	23	Yes	Open	22 ≤ T2,13T3	17 ≤ G2,18G3	No	12 (34)	1 (3)	0 (0)	3 (9)	89 (2)
Nakashima et al. [19]	ONU	38	56	Yes	Open	26 ≤ T2,11T3	24 ≤ G2,13G3	No	21 (55)	1 (3)	0 (0)	2 (5)	91 (2)